The aim is that Growth Analyser will enable pharmaceutical decision-makers to more easily compare and contrast growth trends among countries, gauge the effectiveness of sales strategies, and react quickly to local market changes. According to Rob Stringer, Marketing Manager IMS Health, "Growth Analyser delivers comprehensive and unique insights that can help pharmaceutical manufacturers adapt instantly to the ever-shifting competitive landscape. The service is powered by IMS HEALTH’s MIDAS, which tracks sales, volume and prices for literally thousands of pharmaceutical brands in more than 40 countries. Growth Analyser is all about informed decision-making to improve global sales and marketing productivity." Growth Analyser measures growth from new products, line extensions, price changes, volume changes, exchange rate changes, and the interactive effect of price and volume changes. Insights can be organized and sorted by country, pharmaceutical company, nationality and product classification group. Sales information is provided in local currency, US Dollar, Euro and specific growth categories. The service is available via IMS HEALTH’s Dataview offline database interface, enabling fast, easy and continuous access to Growth Analyser as well as flexible analysis and graphing capabilities.